Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis. - Wikidata - awgldk - TriplyDB

Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis.

Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis.

http://www.wikidata.org/entity/Q33558135

about

Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: recent advances and controversies Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease.Hemophagocytic lymphohistiocytosis in a patient with human immunodeficiency virus infection: A case report.Hemophagocytic Lymphohistiocytosis: A Diagnostic Conundrum.T cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents Haemophagocytic Lymphohistiocytosis manifestations.High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study.Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases.IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH.Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.

P2860

Q26784285-17FB0E8A-CA47-47D8-8341-5AA1D2FA75BF Q35073850-873983EB-608A-4B5A-8F6B-6F859A0374F8 Q38215685-B0154E7A-D560-4041-A0EC-5D0298B161C6 Q38908093-B842BD78-9EA8-4E4B-9EAB-E3A6A16FC708 Q40178750-4E337F09-9BCE-4E11-B58F-7673256F08D2 Q42255863-CEB227E1-8A87-488E-8C7B-14CE4BE182BE Q47550593-9318F44F-E9C3-4B9C-9F78-481689E94ADC Q47763046-AC221886-11BE-4957-8583-54AFE180DCE1 Q48148219-74F8D7A8-20A1-49BE-8C49-2B48A78A4A90 Q48238889-7DD33719-BE44-4522-A175-92DE3E89068C Q48596388-C1E8E74C-CFFF-4938-82A4-5E1E502C81C8

P2860

Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis.

http://www.wikidata.org/entity/Q33558135

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@ast

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@en

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@nl

type

label

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@ast

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@en

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@nl

prefLabel

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@ast

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@en

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@nl

P1433

Q33558135-704B09E1-1AC2-4A8D-B9F7-8CC8D8E498FA

P1476

Q33558135-071A1527-7A98-47FA-B040-7E58098EB45A

P2093

Q33558135-1B12617D-D669-46A2-851E-DDF2941CA466

Q33558135-226D4511-D9E2-4B67-BE6F-FDB7D7A30C56

Q33558135-24D6B7CD-175A-45CA-8127-69A8DA05213F

Q33558135-3598E3D6-3274-4E27-B469-DD3360E027DD

Q33558135-45945EA7-4457-43F9-8054-FA14911DF281

Q33558135-5CBF7168-0C6D-464B-9A52-350C5BE0CEF7

Q33558135-6C08ED26-F796-4C26-8EB4-CA0BC1E96CC6

Q33558135-761EE2FD-E0CE-43A2-AAE7-C22CFCFC1CB2

Q33558135-AE3A5230-B1FC-48BE-8A84-057561A28E9C

Q33558135-BC8AEBCD-5516-4730-9806-9BD1A7D7E455

P2860

Q33558135-04A17283-3AA2-496B-81FC-B89F48AF73F9

Q33558135-0A92FB5C-D7AB-45EF-B70D-FE339412E764

Q33558135-127BB936-E364-415E-8247-A15CBC53D0F0

Q33558135-1AFC5DD5-0455-4C45-815B-19D3C1E5B83B

Q33558135-2E4FCF8B-F81C-4698-B669-4AF8DC39F738

Q33558135-3E7CDB0F-13CE-44AD-ADAD-F0757E23B201

Q33558135-41246B15-4B58-4D06-AB6B-F838656A2268

Q33558135-561E12B9-5500-4483-9E50-FFC45B8E5F64

Q33558135-8DA308EC-D532-43C0-868E-96AACD072A8D

Q33558135-B06073D3-B44A-42D2-8034-5BB16B8D2606

P304

Q33558135-EA112AA8-41A1-40D6-9CCC-12C791E2354C

P31

Q33558135-68F8D6CD-E442-498A-8159-EE748AC2E051

P356

Q33558135-10F3E76E-0632-4E69-8F58-E3B98A100DE5

P433

Q33558135-633A3BBD-BCD6-47A5-9E13-0DB7E31DC8CA

P478

Q33558135-BF9CDEBA-6F2A-43D6-B4A8-B5409DC74D06

P50

Q33558135-41B37F30-243E-452A-8EB8-93B7E0B1FCB9

P577

Q33558135-A247AF78-A026-445E-BF2B-F759A14D56D1

P5875

Q33558135-C6F5EAAA-AC82-4C12-8349-03D0D7CEB5C3

P698

Q33558135-60A88FEC-B8C3-47AD-BA77-38EB47FD0178

P921

Q33558135-CF7B1F68-FDDC-49AC-80C8-0FD8E546EAD8

P932

Q33558135-90F0A558-CE76-4041-8422-6F5F3D6A6A7A

P356

HAEMATOL.2013.094730

P1433

P1476

Treosulfan-based conditioning ...... hagocytic lymphohistiocytosis.

@en

P2093

Ansgar Schulz

http://www.w3.org/2001/XMLSchema#string

Bernd Gruhn

http://www.w3.org/2001/XMLSchema#string

Daniel Stachel

http://www.w3.org/2001/XMLSchema#string

Gritta Janka

http://www.w3.org/2001/XMLSchema#string

Kai Lehmberg

http://www.w3.org/2001/XMLSchema#string

Karin Beutel

http://www.w3.org/2001/XMLSchema#string

Michael H Albert

http://www.w3.org/2001/XMLSchema#string

Nicolaus Kröger

http://www.w3.org/2001/XMLSchema#string

Rita Beier

http://www.w3.org/2001/XMLSchema#string

Roland Meisel

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients.

Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases

The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis.

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.

Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab.

Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.

P304

180-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2013.094730

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258102837

http://www.w3.org/2001/XMLSchema#string

P698

24162790

http://www.w3.org/2001/XMLSchema#string

P921

P932

4007927

http://www.w3.org/2001/XMLSchema#string